Zhejiang Xianju Pharmaceutical Co Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Xianju Pharmaceutical Co Limited with three other
companies in this sector in China:
SSY Group Ltd
sales of 3.53 billion Chinese Renmimbi [US$498.67 million]
of which 96%
was Intravenous Infusion Solution and Others),
Cisen Pharmaceutical Co Ltd
(3.80 billion Chinese Renmimbi [US$537.17 million]
of which 55%
was Large infusion), and
Haisco Pharmaceutical Group Co Ltd
(3.43 billion Chinese Renmimbi [US$483.84 million]
of which 71%
was Parent company).
Zhejiang Xianju Pharmaceutical Co Limited reported sales of 3.62 billion Chinese Renmimbi (US$511.39 million)
December of 2018.
increase of 27.0%
versus 2017, when the company's sales were 2.85 billion Chinese Renmimbi.
Sales at Zhejiang Xianju Pharmaceutical Co Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 57%).
Sales of Others saw an increase
44.6% in 2018, from
6.58 million Chinese Renmimbi to 9.51 million Chinese Renmimbi.